act legal Germany advised the owners on the sale of all shares in the companies of the Axel Semrau Group to the Trajan Scientific and Medical Group (“Trajan“), a listed company from Australia.
Axel Semrau has been active in the sales and support of special solutions for sample preparation and chromatography, chemical synthesis and application-optimized workstations for more than 35 years and develops its own hardware and software solutions in order to offer unique and above-average automation solutions can.
Trajan, headquartered in Melbourne, currently operates in Australia, the USA and Malaysia and manufactures devices for the analysis of biological, food and environmental samples. The Axel Semrau Group is, among other things, the owner and developer of the intelligent sequencing software platform CHRONOS, on which Trajan’s automated work processes are based. Against this background, Trajan, together with the previous management team, is planning a further growth strategy to simplify and automate complex analytical work processes.
act legal – with more than 300 professionals throughout Central Europe – act legal offers sophisticated national and international legal advice – the attractive alternative to major international law firms.
act legal Germany maintains a long-term client relationship with Axel Semrau and advised the shareholders on all aspects of the transaction.
Consultants Axel Semrau
act legal Germany: Dr. Fabian Brocke, LL.M. (M&A, lead); Dr. Nina Honstetter (Corporate, Employment); Anna Gatzweiler (IP/IT)
Moog Partnerschaftsgesellschaft mbB: Marc Sälzer (Tax)